Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants Gabe 2024 Diabetes, Obesity and Metabolism Wiley Online Library Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect You thought Ozempic was big? Just wait. The next generation of weight loss medications is already in clinical trials oral pills, monthly injections, and even triple action drugs that may work better than Cagrilintide: Effective Weekly Dosage and Weight Loss Benefits Explained Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment Journal of Medicinal Chemistry